DZ876A1 - Pharmaceutically active compound and process for its preparation. - Google Patents
Pharmaceutically active compound and process for its preparation.Info
- Publication number
- DZ876A1 DZ876A1 DZ850275A DZ850275A DZ876A1 DZ 876 A1 DZ876 A1 DZ 876A1 DZ 850275 A DZ850275 A DZ 850275A DZ 850275 A DZ850275 A DZ 850275A DZ 876 A1 DZ876 A1 DZ 876A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- active compound
- pharmaceutically active
- pharmaceutically
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8406660 | 1984-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ876A1 true DZ876A1 (en) | 2004-09-13 |
Family
ID=20358339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ850275A DZ876A1 (en) | 1984-12-28 | 1985-12-28 | Pharmaceutically active compound and process for its preparation. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4788216A (en) |
EP (1) | EP0207124B1 (en) |
JP (2) | JPH0720966B2 (en) |
CN (1) | CN1006795B (en) |
AP (1) | AP32A (en) |
AT (1) | ATE68186T1 (en) |
AU (1) | AU585936B2 (en) |
CA (1) | CA1255230A (en) |
DE (1) | DE3584370D1 (en) |
DK (1) | DK169506B1 (en) |
DZ (1) | DZ876A1 (en) |
EG (1) | EG17788A (en) |
ES (1) | ES8701761A1 (en) |
FI (1) | FI89330C (en) |
GR (1) | GR853145B (en) |
HU (1) | HU201672B (en) |
IL (1) | IL77456A (en) |
MA (1) | MA20602A1 (en) |
NO (1) | NO863329L (en) |
PT (1) | PT81760B (en) |
TN (1) | TNSN86004A1 (en) |
WO (1) | WO1986004062A1 (en) |
ZA (1) | ZA859881B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4644072A (en) * | 1985-04-12 | 1987-02-17 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
AU632796B2 (en) * | 1989-02-23 | 1993-01-14 | University Of North Carolina At Chapel Hill, The | Etoposide analogues |
SE464167B (en) | 1989-07-31 | 1991-03-18 | Analytecon Sa | TOPICAL PHARMACEUTICAL PREPARATION OF PODOPHYLLOTOXIN |
US5332811A (en) * | 1989-09-12 | 1994-07-26 | The University Of North Carolina At Chapel Hill | Etopside analogs |
US5338867A (en) * | 1992-04-24 | 1994-08-16 | Genelabs Technologies, Inc. | Preparation of 4β- amino podophyllotoxin compounds |
SE9301831D0 (en) * | 1993-05-28 | 1993-05-28 | Analytecon S A | PHARMACEUTICAL COMPOSITIONS |
GB9422947D0 (en) * | 1994-11-14 | 1995-01-04 | Univ Salamanca | Immunosuppressive cyclolignan derivatives |
US6051721A (en) * | 1997-10-02 | 2000-04-18 | The Board Of Regents Of The University Of Nebraska | Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis |
FI105152B (en) | 1998-07-17 | 2000-06-30 | Eero Saarela | Local pain relief procedure |
US6143304A (en) * | 1999-08-17 | 2000-11-07 | The University Of Mississippi | Enhanced yield of podophyllotoxin from natural products through in situ conversion methods |
SE0102168D0 (en) | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
DE60233601D1 (en) * | 2001-06-19 | 2009-10-15 | Axelar Ab | Use of certain cyclolignans |
SE0203746D0 (en) * | 2002-12-18 | 2002-12-18 | Karolinska Innovations Ab | New compounds |
CA2728652A1 (en) * | 2008-06-23 | 2009-12-30 | Axelar Ab | Use of cyclolignans for the treatment of a hyperactive immune system |
EP2817007A1 (en) * | 2012-02-24 | 2014-12-31 | Nestec S.A. | Peltatin for the treatment of chronic inflammatory disorders |
WO2015028456A1 (en) * | 2013-08-28 | 2015-03-05 | Nestec S.A. | PPAR modulators |
JOP20190254A1 (en) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | Antitumoral compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA635769A (en) * | 1962-01-30 | Rutschmann Jurg | Amides of podophyllic acid and picropodophyllic acid | |
SE335139B (en) * | 1964-08-12 | 1971-05-17 | Sandoz Ag | |
US4122092A (en) * | 1977-08-25 | 1978-10-24 | University Of Rochester | Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone |
US4567253A (en) * | 1984-02-03 | 1986-01-28 | Tony Durst | 2-Substituted derivatives of podophyllotoxin and etoposide |
GB8424269D0 (en) * | 1984-09-26 | 1984-10-31 | Pharma Medica As | Isolation and purification of podophyllotoxin |
-
1985
- 1985-12-20 JP JP61500490A patent/JPH0720966B2/en not_active Expired - Lifetime
- 1985-12-20 EP EP86900345A patent/EP0207124B1/en not_active Expired - Lifetime
- 1985-12-20 WO PCT/SE1985/000541 patent/WO1986004062A1/en active IP Right Grant
- 1985-12-20 AU AU53003/86A patent/AU585936B2/en not_active Ceased
- 1985-12-20 DE DE8686900345T patent/DE3584370D1/en not_active Expired - Fee Related
- 1985-12-20 US US06/908,801 patent/US4788216A/en not_active Expired - Lifetime
- 1985-12-20 HU HU86777D patent/HU201672B/en not_active IP Right Cessation
- 1985-12-20 AT AT86900345T patent/ATE68186T1/en not_active IP Right Cessation
- 1985-12-23 AP APAP/P/1985/000017A patent/AP32A/en active
- 1985-12-24 CA CA000498645A patent/CA1255230A/en not_active Expired
- 1985-12-25 EG EG828/85A patent/EG17788A/en active
- 1985-12-26 MA MA20828A patent/MA20602A1/en unknown
- 1985-12-26 PT PT81760A patent/PT81760B/en not_active IP Right Cessation
- 1985-12-26 IL IL77456A patent/IL77456A/en unknown
- 1985-12-27 GR GR853145A patent/GR853145B/el not_active IP Right Cessation
- 1985-12-27 ES ES550504A patent/ES8701761A1/en not_active Expired
- 1985-12-27 CN CN85109666A patent/CN1006795B/en not_active Expired
- 1985-12-28 DZ DZ850275A patent/DZ876A1/en active
- 1985-12-30 ZA ZA859881A patent/ZA859881B/en unknown
-
1986
- 1986-01-09 TN TNTNSN86004A patent/TNSN86004A1/en unknown
- 1986-08-19 NO NO863329A patent/NO863329L/en unknown
- 1986-08-27 DK DK408186A patent/DK169506B1/en not_active IP Right Cessation
- 1986-08-27 FI FI863482A patent/FI89330C/en not_active IP Right Cessation
-
1994
- 1994-10-14 JP JP6274258A patent/JP2572558B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ876A1 (en) | Pharmaceutically active compound and process for its preparation. | |
NO163131C (en) | Analogous Process for Preparation of Therapeutically Active Pyridine Derivatives. | |
PL269091A1 (en) | Method for manufacturing new pharmacologically active derivatives of catechine | |
ZA827898B (en) | A compound having analgesic,anti-inflammatory and muco-regulatory activity,a method for the preparation thereof and related pharmaceutical compounds | |
IL67172A (en) | Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,process for their preparation and pharmaceutical agents containing these compounds | |
NO173544C (en) | Analogous Procedure for Preparation of Therapeutically Active 2-Thiomethyl-substituted 1,4-dihydropyridines | |
OA09014A (en) | New cepheme and process for its preparation. | |
NO162113C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PHENETANOLAMINE COMPOUNDS. | |
HUT40918A (en) | Process for producing new galenic compositions with retard dissolution of the active agents | |
NO864879D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE THIASOL COMPOUNDS. | |
IT8547927A0 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A BETA-BLOCKER COMPOUND FOR THE PROPHYLAXIS AND TREATMENT OF HEART DISORDERS | |
PT86000A (en) | Pharmaceutically active compounds | |
NO153099C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC ACTIVE 5,5`-AZOBIS-SALICYLIC ACID COMPOUND | |
FI871087A (en) | Process for the preparation of therapeutically active 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo / oxo-5-pyrimidinecarboxylic acid derivatives | |
FI884471A0 (en) | Process for the preparation of therapeutically active dihydropyridine compounds | |
OA08384A (en) | Process for preparing urea. | |
NO165842C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CEFEM COMPOUNDS. | |
FI91964C (en) | Process for the preparation of new pharmaceutically active 1- (hydroxystyryl) -5H-2,3-benzodiazepine derivatives | |
FR2571713B1 (en) | PROCESS FOR THE PREPARATION OF TITANATES, ZIRCONATES AND STANNATES | |
OA07984A (en) | Stereocontrolled process for the preparation of acetoxyazetidione. | |
NO163330C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE ISOQINOLINE DERIVATIVES. | |
FR2522266B1 (en) | PROCESS FOR THE PREPARATION OF A FIBRINOLYTICALLY ACTIVE AGENT AND AGENT OBTAINED | |
ZA875174B (en) | A method for the preparation of a therapeutically active compound | |
NO160712C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BENZOTIAZEPINE COMPOUNDS. | |
NO171499C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6-DIHYDRO-4H-CYCLO-PENTA (B) THIOFEN-6-CARBOXYLIC ACID DERIVATIVES |